Literature DB >> 11053416

Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs.

K Els Conrath1, M Lauwereys, L Wyns, S Muyldermans.   

Abstract

Single-domain antibodies against various antigens are isolated from the unique heavy-chain antibodies of immunized camels and llamas. These minimal sized binders are very robust and bind the antigen with high affinity in a monomeric state. We evaluated the feasibility to produce soluble, functional bispecific and bivalent antibodies in Escherichia coli with camel single-domain antibody fragments as building blocks. Two single-domain antibody fragments were tethered by the structural upper hinge of a natural antibody to generate bispecific molecules. This linker was chosen for its protease resistance in serum and its natural flexibility to reorient the upstream and downstream located domains. The expression levels, ease of purification, and the solubility of the recombinant proteins were comparable with those of the constituent monomers. The individual moieties fully retain the binding capacity and the binding characteristics within the recombinant bispecific constructs. The easy generation steps and the biophysical properties of these bispecific and bivalent constructs based on camel single-domain antibody fragments makes them particularly attractive for use in therapeutic or diagnostic programs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053416     DOI: 10.1074/jbc.M007734200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  A novel bispecific antibody, BiSS, with potent anti-cancer activities.

Authors:  Bin Dong; Changhua Zhou; Ping He; Jing Li; Siqi Chen; Ji Miao; Qing Li; Zhong Wang
Journal:  Cancer Biol Ther       Date:  2016-02-01       Impact factor: 4.742

2.  Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection.

Authors:  Hans J W De Haard; Sandra Bezemer; Aat M Ledeboer; Wally H Müller; Piet J Boender; Sylvain Moineau; Marie-Cecile Coppelmans; Arie J Verkleij; Leon G J Frenken; C Theo Verrips
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

3.  Site-directed integration of transgenes: transposons revisited using DNA-binding-domain technologies.

Authors:  Marie-Véronique Demattei; Xavier Thomas; Elodie Carnus; Corinne Augé-Gouillou; Sylvaine Renault
Journal:  Genetica       Date:  2009-08-07       Impact factor: 1.082

Review 4.  Bispecific antibodies in cancer immunotherapy.

Authors:  Siqi Chen; Jing Li; Qing Li; Zhong Wang
Journal:  Hum Vaccin Immunother       Date:  2016-06-01       Impact factor: 3.452

5.  Kinetic analysis of novel mono- and multivalent VHH-fragments and their application for molecular imaging of brain tumours.

Authors:  U Iqbal; U Trojahn; H Albaghdadi; J Zhang; M O'Connor-McCourt; D Stanimirovic; B Tomanek; G Sutherland; A Abulrob
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  Nanobody-coupled microbubbles as novel molecular tracer.

Authors:  Sophie Hernot; Sunil Unnikrishnan; Zhongmin Du; Talent Shevchenko; Bernard Cosyns; Alexis Broisat; Jakub Toczek; Vicky Caveliers; Serge Muyldermans; Tony Lahoutte; Alexander L Klibanov; Nick Devoogdt
Journal:  J Control Release       Date:  2011-12-16       Impact factor: 9.776

Review 7.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Authors:  William R Strohl; Michael Naso
Journal:  Antibodies (Basel)       Date:  2019-07-03

8.  Evaluation of antidiphtheria toxin nanobodies.

Authors:  Ghada H Shaker
Journal:  Nanotechnol Sci Appl       Date:  2010-06-17

9.  Heavy chain single-domain antibodies to detect native human soluble epoxide hydrolase.

Authors:  Yongliang Cui; Dongyang Li; Christophe Morisseau; Jie-Xian Dong; Jun Yang; Debin Wan; Martín A Rossotti; Shirley J Gee; Gualberto G González-Sapienza; Bruce D Hammock
Journal:  Anal Bioanal Chem       Date:  2015-07-31       Impact factor: 4.142

Review 10.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.